Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
ClinicalTrials.gov study NCT06125795. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03289182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01671904. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
ClinicalTrials.gov study NCT03467867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
ClinicalTrials.gov study NCT05536349. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
ClinicalTrials.gov study NCT07342478. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Study to Evaluate ICP-022 in Patients With CLL/ SLL
ClinicalTrials.gov study NCT03493217. IPD Sharing: NO. Countries: 1. Publications: 0.
High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL
ClinicalTrials.gov study NCT00828282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT04305444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
ClinicalTrials.gov study NCT03545035. IPD Sharing: NO. Countries: 1. Publications: 0.
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
ClinicalTrials.gov study NCT01397149. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
ClinicalTrials.gov study NCT05360238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
ClinicalTrials.gov study NCT05999877. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
ClinicalTrials.gov study NCT00078520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients
ClinicalTrials.gov study NCT02137889. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ALICIA (Acalabrutinib in CLL Therapy)
ClinicalTrials.gov study NCT04746950. IPD Sharing: YES. Countries: 1. Publications: 0.
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
ClinicalTrials.gov study NCT04269902. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1
ClinicalTrials.gov study NCT06136559. IPD Sharing: YES. Countries: 29. Publications: 0.
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
ClinicalTrials.gov study NCT03960840. IPD Sharing: NO. Countries: 8. Publications: 0.
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT06520098. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.